Real health improvements come from eating better foods, not from adding pills to poor eating habits
Future randomized, dermatology-specific trials should stratify by obesity and diabetes status, capture early immunologic and imaging biomarkers, and focus on outcomes that matter directly to patients, such as pain, work and school attendance, and procedure burden
Phase 2 clinical trials published in 2023 demonstrated unprecedented weight loss efficacy, with participants achieving up to 24.2% body weight reduction over 48 weeks results approaching those typically observed only with bariatric surgery[1]
Both medications show similar timelines, with noticeable appetite reduction within 1-2 weeks and visible weight loss by weeks 8-12
The statin-treated patients had different levels of certain secondary bile acids compounds made by gut bacteria
It is built around ready-to-eat grocery foods, not cooking projects